Reference : Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy.
Scientific journals : Article
Human health sciences : Oncology
Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy.
Moules, Vincent [> > > >]
Pomier, Carole [> > > >]
Sibon, David [> > > >]
Gabet, Anne-Sophie [> > > >]
Reichert, Michal [> > > >]
Kerkhofs, Pierre [> > > >]
Willems, Luc mailto [Université de Liège - ULiège > > GIGA-Research >]
Mortreux, Franck [> > > >]
Wattel, Eric [> > > >]
Cancer Research
American Association for Cancer Research, Inc. (AACR)
Yes (verified by ORBi)
[en] Animals ; Cattle ; Cell Transformation, Viral/physiology ; Clone Cells ; DNA, Neoplasm/genetics ; Leukemia/genetics/pathology/virology ; Leukemia Virus, Bovine/genetics ; Lymphoma/genetics/pathology/virology ; Mutation ; Precancerous Conditions/genetics/pathology/virology ; Sheep ; Sheep Diseases/virology ; Virus Integration
[en] Almost all cancers are preceded by a prolonged period of clinical latency during which a combination of cellular events helps move carcinogen-exposed cells towards a malignant phenotype. Hitherto, investigating the fate of premalignant cells in vivo remained strongly hampered by the fact that these cells are usually indistinguishable from their normal counterparts. Here, for the first time, we have designed a strategy able to reconstitute the replicative history of the bona fide premalignant clone in an animal model, the sheep experimentally infected with the lymphotropic bovine leukemia virus. We have shown that premalignant clones are early and clearly distinguished from other virus-exposed cells on the basis of their degree of clonal expansion and genetic instability. Detectable as early as 0.5 month after the beginning of virus exposure, premalignant cells displayed a two-step pattern of extensive clonal expansion together with a mutation load approximately 6 times higher than that of other virus-exposed cells that remained untransformed during the life span of investigated animals. There was no fixation of somatic mutations over time, suggesting that they regularly lead to cellular death, partly contributing to maintain a normal lymphocyte count during the prolonged premalignant stage. This equilibrium was finally broken after a period of 18.5 to 60 months of clinical latency, when a dramatic decrease in the genetic instability of premalignant cells coincided with a rapid increase in lymphocyte count and lymphoma onset.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Moules 05.pdfPublisher postprint907.13 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.